- Área de investigación
-
- Biología y Biomedicina
- Importe
- 95.000,00 €
Novel inhibitors of the inflammasome for the mitigation of SARS-CoV- 2 pathogenic effects in human type II pneumocytes and transgenic mouse models
Integrantes: